{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:22:25Z","timestamp":1788960145153,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K09836"],"award-info":[{"award-number":["16K09836"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K16174"],"award-info":[{"award-number":["17K16174"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00277-023-05405-0","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T14:02:40Z","timestamp":1692453760000},"page":"3103-3113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"102","author":[{"given":"Hiroyuki","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9267-2864","authenticated-orcid":false,"given":"Masahiro","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Oguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Kakinoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuto","family":"Miyagishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Wakasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Haseyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimichi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,19]]},"reference":[{"issue":"1","key":"5405_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0092-8674(94)90407-3","volume":"79","author":"K Georgopoulos","year":"1994","unstructured":"Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S, Sharpe A (1994) The Ikaros gene is required for the development of all lymphoid lineages. Cell 79(1):143\u2013156","journal-title":"Cell"},{"issue":"3","key":"5405_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri747","volume":"2","author":"K Georgopoulos","year":"2002","unstructured":"Georgopoulos K (2002) Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol 2(3):162\u2013174. https:\/\/doi.org\/10.1038\/nri747","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5405_CR3","first-page":"1","volume":"3","author":"P Kastner","year":"2013","unstructured":"Kastner P, Dupuis A, Gaub MP, Herbrecht R, Lutz P, Chan S (2013) Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia. Am J Blood Res 3(1):1\u201313","journal-title":"Am J Blood Res"},{"issue":"4","key":"5405_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/bjh.13342","volume":"169","author":"L Olsson","year":"2015","unstructured":"Olsson L, Johansson B (2015) Ikaros and leukaemia. Br J Haematol 169(4):479\u2013491. https:\/\/doi.org\/10.1111\/bjh.13342","journal-title":"Br J Haematol"},{"issue":"9\u201310","key":"5405_CR5","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.molimm.2011.03.006","volume":"48","author":"LB John","year":"2011","unstructured":"John LB, Ward AC (2011) The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Mol Immunol 48(9\u201310):1272\u20131278. https:\/\/doi.org\/10.1016\/j.molimm.2011.03.006","journal-title":"Mol Immunol"},{"issue":"5","key":"5405_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJMoa0808253","volume":"360","author":"CG Mullighan","year":"2009","unstructured":"Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, Ma J, Liu W, Cheng C, Schulman BA, Harvey RC, Chen IM, Clifford RJ, Carroll WL, Reaman G, Bowman WP, Devidas M, Gerhard DS, Yang W, Relling MV, Shurtleff SA, Campana D, Borowitz MJ, Pui CH, Smith M, Hunger SP, Willman CL, Downing JR, Children\u2019s Oncology G (2009) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360(5):470\u2013480. https:\/\/doi.org\/10.1056\/NEJMoa0808253","journal-title":"N Engl J Med"},{"issue":"3","key":"5405_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/cam4.87","volume":"2","author":"D Asai","year":"2013","unstructured":"Asai D, Imamura T, Suenobu S, Saito A, Hasegawa D, Deguchi T, Hashii Y, Matsumoto K, Kawasaki H, Hori H, Iguchi A, Kosaka Y, Kato K, Horibe K, Yumura-Yagi K, Hara J, Oda M, Japan Association of Childhood Leukemia S (2013) IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan. Cancer Med 2(3):412\u2013419. https:\/\/doi.org\/10.1002\/cam4.87","journal-title":"Cancer Med"},{"issue":"1","key":"5405_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/leu.2015.199","volume":"30","author":"JM Boer","year":"2016","unstructured":"Boer JM, van der Veer A, Rizopoulos D, Fiocco M, Sonneveld E, de Groot-Kruseman HA, Kuiper RP, Hoogerbrugge P, Horstmann M, Zaliova M, Palmi C, Trka J, Fronkova E, Emerenciano M, do Socorro Pombo-de-Oliveira M, Mlynarski W, Szczepanski T, Nebral K, Attarbaschi A, Venn N, Sutton R, Schwab CJ, Enshaei A, Vora A, Stanulla M, Schrappe M, Cazzaniga G, Conter V, Zimmermann M, Moorman AV, Pieters R, den Boer ML (2016) Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study. Leukemia 30(1):32\u201338. https:\/\/doi.org\/10.1038\/leu.2015.199","journal-title":"Leukemia"},{"issue":"31","key":"5405_CR9","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1200\/JCO.2008.21.6408","volume":"27","author":"G Martinelli","year":"2009","unstructured":"Martinelli G, Iacobucci I, Storlazzi CT, Vignetti M, Paoloni F, Cilloni D, Soverini S, Vitale A, Chiaretti S, Cimino G, Papayannidis C, Paolini S, Elia L, Fazi P, Meloni G, Amadori S, Saglio G, Pane F, Baccarani M, Foa R (2009) IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol 27(31):5202\u20135207. https:\/\/doi.org\/10.1200\/JCO.2008.21.6408","journal-title":"J Clin Oncol"},{"issue":"15","key":"5405_CR10","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","volume":"122","author":"A van der Veer","year":"2013","unstructured":"van der Veer A, Waanders E, Pieters R, Willemse ME, Van Reijmersdal SV, Russell LJ, Harrison CJ, Evans WE, van der Velden VH, Hoogerbrugge PM, Van Leeuwen F, Escherich G, Horstmann MA, Mohammadi Khankahdani L, Rizopoulos D, De Groot-Kruseman HA, Sonneveld E, Kuiper RP, Den Boer ML (2013) Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. Blood 122(15):2622\u20132629. https:\/\/doi.org\/10.1182\/blood-2012-10-462358","journal-title":"Blood"},{"issue":"10","key":"5405_CR11","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood-2008-08-173963","volume":"114","author":"I Iacobucci","year":"2009","unstructured":"Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S, Astolfi A, Chiaretti S, Vitale A, Messa F, Impera L, Baldazzi C, D\u2019Addabbo P, Papayannidis C, Lonoce A, Colarossi S, Vignetti M, Piccaluga PP, Paolini S, Russo D, Pane F, Saglio G, Baccarani M, Foa R, Martinelli G (2009) Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell\u2019Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood 114(10):2159\u20132167. https:\/\/doi.org\/10.1182\/blood-2008-08-173963","journal-title":"Blood"},{"issue":"7","key":"5405_CR12","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/leu.2010.87","volume":"24","author":"RP Kuiper","year":"2010","unstructured":"Kuiper RP, Waanders E, van der Velden VH, van Reijmersdal SV, Venkatachalam R, Scheijen B, Sonneveld E, van Dongen JJ, Veerman AJ, van Leeuwen FN, van Kessel AG, Hoogerbrugge PM (2010) IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia 24(7):1258\u20131264. https:\/\/doi.org\/10.1038\/leu.2010.87","journal-title":"Leukemia"},{"issue":"10","key":"5405_CR13","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1111\/j.1349-7006.2011.02031.x","volume":"102","author":"YL Yang","year":"2011","unstructured":"Yang YL, Hung CC, Chen JS, Lin KH, Jou ST, Hsiao CC, Sheen JM, Cheng CN, Wu KH, Lin SR, Yu SL, Chen HY, Lu MY, Wang SC, Chang HH, Lin SW, Su YN, Lin DT (2011) IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan. Cancer Sci 102(10):1874\u20131881. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.02031.x","journal-title":"Cancer Sci"},{"issue":"7","key":"5405_CR14","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/leu.2012.23","volume":"26","author":"JQ Mi","year":"2012","unstructured":"Mi JQ, Wang X, Yao Y, Lu HJ, Jiang XX, Zhou JF, Wang JH, Jiao B, Shen SH, Tang JY, Gu LJ, Jiang H, Ma LY, Hao SG, Chen FY, Xiong SM, Shen ZX, Chen Z, Chen B, Chen SJ (2012) Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases. Leukemia 26(7):1507\u20131516. https:\/\/doi.org\/10.1038\/leu.2012.23","journal-title":"Leukemia"},{"issue":"2","key":"5405_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/leu.2012.155","volume":"27","author":"S Krentz","year":"2013","unstructured":"Krentz S, Hof J, Mendioroz A, Vaggopoulou R, Dorge P, Lottaz C, Engelmann JC, Groeneveld TW, Korner G, Seeger K, Hagemeier C, Henze G, Eckert C, von Stackelberg A, Kirschner-Schwabe R (2013) Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia 27(2):295\u2013304. https:\/\/doi.org\/10.1038\/leu.2012.155","journal-title":"Leukemia"},{"issue":"2","key":"5405_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/leu.2010.275","volume":"25","author":"E Waanders","year":"2011","unstructured":"Waanders E, van der Velden VH, van der Schoot CE, van Leeuwen FN, van Reijmersdal SV, de Haas V, Veerman AJ, van Kessel AG, Hoogerbrugge PM, Kuiper RP, van Dongen JJ (2011) Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia. Leukemia 25(2):254\u2013258. https:\/\/doi.org\/10.1038\/leu.2010.275","journal-title":"Leukemia"},{"issue":"1","key":"5405_CR17","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1038\/s41598-019-41078-4","volume":"9","author":"EMP Steeghs","year":"2019","unstructured":"Steeghs EMP, Boer JM, Hoogkamer AQ, Boeree A, de Haas V, de Groot-Kruseman HA, Horstmann MA, Escherich G, Pieters R, den Boer ML (2019) Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia. Sci Rep 9(1):4634. https:\/\/doi.org\/10.1038\/s41598-019-41078-4","journal-title":"Sci Rep"},{"issue":"11","key":"5405_CR18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1182\/blood-2013-06-509794","volume":"123","author":"A van der Veer","year":"2014","unstructured":"van der Veer A, Zaliova M, Mottadelli F, De Lorenzo P, Te Kronnie G, Harrison CJ, Cave H, Trka J, Saha V, Schrappe M, Pieters R, Biondi A, Valsecchi MG, Stanulla M, den Boer ML, Cazzaniga G (2014) IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL. Blood 123(11):1691\u20131698. https:\/\/doi.org\/10.1182\/blood-2013-06-509794","journal-title":"Blood"},{"issue":"6","key":"5405_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/PAT.0b013e3283653bd1","volume":"45","author":"J O\u2019Reilly","year":"2013","unstructured":"O\u2019Reilly J, Russell LJ, Cooney J, Ensor HM, Purtill D, Wright M, Moorman AV (2013) Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemia. Pathology 45(6):609\u2013612. https:\/\/doi.org\/10.1097\/PAT.0b013e3283653bd1","journal-title":"Pathology"},{"key":"5405_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12885-016-2300-7","volume":"16","author":"QM Yao","year":"2016","unstructured":"Yao QM, Liu KY, Gale RP, Jiang B, Liu YR, Jiang Q, Jiang H, Zhang XH, Zhang MJ, Chen SS, Huang XJ, Xu LP, Ruan GR (2016) Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia. BMC Cancer 16:269. https:\/\/doi.org\/10.1186\/s12885-016-2300-7","journal-title":"BMC Cancer"},{"issue":"19","key":"5405_CR21","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1002\/j.1460-2075.1996.tb00920.x","volume":"15","author":"L Sun","year":"1996","unstructured":"Sun L, Liu A, Georgopoulos K (1996) Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J 15(19):5358\u20135369","journal-title":"EMBO J"},{"key":"5405_CR22","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.161273","author":"B Kobitzsch","year":"2017","unstructured":"Kobitzsch B, Gokbuget N, Schwartz S, Reinhardt R, Bruggemann M, Viardot A, Wasch R, Starck M, Thiel E, Hoelzer D, Burmeister T (2017) Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2016.161273","journal-title":"Haematologica"},{"issue":"4","key":"5405_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jmoldx.2018.02.005","volume":"20","author":"J Hashiguchi","year":"2018","unstructured":"Hashiguchi J, Onozawa M, Oguri S, Fujisawa S, Tsuji M, Okada K, Nakagawa M, Hashimoto D, Kahata K, Kondo T, Shimizu C, Teshima T (2018) Development of a fluorescence in situ hybridization probe for detecting IKZF1 deletion mutations in patients with acute lymphoblastic leukemia. J Mol Diagn 20(4):446\u2013454. https:\/\/doi.org\/10.1016\/j.jmoldx.2018.02.005","journal-title":"J Mol Diagn"},{"issue":"4","key":"5405_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3324\/haematol.2012.073965","volume":"98","author":"A Caye","year":"2013","unstructured":"Caye A, Beldjord K, Mass-Malo K, Drunat S, Soulier J, Gandemer V, Baruchel A, Bertrand Y, Cave H, Clappier E (2013) Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia. Haematologica 98(4):597\u2013601. https:\/\/doi.org\/10.3324\/haematol.2012.073965","journal-title":"Haematologica"},{"issue":"3","key":"5405_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48(3):452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"5405_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/Gcc.21942","volume":"51","author":"M Onozawa","year":"2012","unstructured":"Onozawa M, Aplan PD (2012) Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy. Genes Chromosom Cancer 51(6):525\u2013535. https:\/\/doi.org\/10.1002\/Gcc.21942","journal-title":"Genes Chromosom Cancer"},{"issue":"2","key":"5405_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/leu.2012.204","volume":"27","author":"A Dupuis","year":"2013","unstructured":"Dupuis A, Gaub MP, Legrain M, Drenou B, Mauvieux L, Lutz P, Herbrecht R, Chan S, Kastner P (2013) Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations. Leukemia 27(2):503\u2013507. https:\/\/doi.org\/10.1038\/leu.2012.204","journal-title":"Leukemia"},{"issue":"7191","key":"5405_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature06866","volume":"453","author":"CG Mullighan","year":"2008","unstructured":"Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, White D, Hughes TP, Le Beau MM, Pui CH, Relling MV, Shurtleff SA, Downing JR (2008) BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453(7191):110\u2013114. https:\/\/doi.org\/10.1038\/nature06866","journal-title":"Nature"},{"issue":"10","key":"5405_CR29","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/pbc.24571","volume":"60","author":"Y Yamashita","year":"2013","unstructured":"Yamashita Y, Shimada A, Yamada T, Yamaji K, Hori T, Tsurusawa M, Watanabe A, Kikuta A, Asami K, Saito AM, Horibe K (2013) IKZF1 and CRLF2 gene alterations correlate with poor prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor acute lymphoblastic leukemia. Pediatr Blood Cancer 60(10):1587\u20131592. https:\/\/doi.org\/10.1002\/pbc.24571","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"5405_CR30","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1016\/j.clml.2021.03.007","volume":"21","author":"SK Gupta","year":"2021","unstructured":"Gupta SK, Bakhshi S, Gupta R, Sharma P, Pushpam D, Sahoo RK, Kamal VK (2021) IKZF1 deletion subtyping and outcome analysis in BCR-ABL1-negative pediatric B-cell acute lymphoblastic leukemia: a single-institution experience from North India. Clin Lymphoma Myeloma Leuk 21(8):e666\u2013e673. https:\/\/doi.org\/10.1016\/j.clml.2021.03.007","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"5405_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/bmt.2014.281","volume":"50","author":"M Kim","year":"2015","unstructured":"Kim M, Park J, Kim DW, Kim YJ, Jeon YW, Yoon JH, Shin SH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim HJ, Min CK, Cho SG, Kim Y, Lee JW, Han K, Min WS, Lee S (2015) Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL. Bone Marrow Transplant 50(3):354\u2013362. https:\/\/doi.org\/10.1038\/bmt.2014.281","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"5405_CR32","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3324\/haematol.2018.196055","volume":"104","author":"AL Fedullo","year":"2019","unstructured":"Fedullo AL, Messina M, Elia L, Piciocchi A, Gianfelici V, Lauretti A, Soddu S, Puzzolo MC, Minotti C, Ferrara F, Martino B, Chiusolo P, Calafiore V, Paolini S, Vignetti M, Vitale A, Guarini A, Foa R, Chiaretti S (2019) Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica 104(2):312\u2013318. https:\/\/doi.org\/10.3324\/haematol.2018.196055","journal-title":"Haematologica"},{"issue":"2","key":"5405_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00277-016-2869-6","volume":"96","author":"W Zhang","year":"2017","unstructured":"Zhang W, Kuang P, Li H, Wang F, Wang Y (2017) Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis. Ann Hematol 96(2):215\u2013225. https:\/\/doi.org\/10.1007\/s00277-016-2869-6","journal-title":"Ann Hematol"},{"issue":"15","key":"5405_CR34","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350(15):1535\u20131548. https:\/\/doi.org\/10.1056\/NEJMra023001","journal-title":"N Engl J Med"},{"issue":"9","key":"5405_CR35","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.6004\/jnccn.2021.0042","volume":"19","author":"PA Brown","year":"2021","unstructured":"Brown PA, Shah B, Advani A, Aoun P, Boyer MW, Burke PW, DeAngelo DJ, Dinner S, Fathi AT, Gauthier J, Jain N, Kirby S, Liedtke M, Litzow M, Logan A, Luger S, Maness LJ, Massaro S, Mattison RJ, May W, Oluwole O, Park J, Przespolewski A, Rangaraju S, Rubnitz JE, Uy GL, Vusirikala M, Wieduwilt M, Lynn B, Berardi RA, Freedman-Cass DA, Campbell M (2021) Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19(9):1079\u20131109. https:\/\/doi.org\/10.6004\/jnccn.2021.0042","journal-title":"J Natl Compr Canc Netw"},{"issue":"21","key":"5405_CR36","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1002\/cncr.29579","volume":"121","author":"J Ribera","year":"2015","unstructured":"Ribera J, Morgades M, Zamora L, Montesinos P, Gomez-Segui I, Pratcorona M, Sarra J, Guardia R, Nomdedeu J, Tormo M, Martinez-Lopez J, Hernandez-Rivas JM, Gonzalez-Campos J, Barba P, Escoda L, Genesca E, Sole F, Milla F, Feliu E, Ribera JM, Spanish PG, the Spanish Society of H (2015) Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols. Cancer 121(21):3809\u20133817. https:\/\/doi.org\/10.1002\/cncr.29579","journal-title":"Cancer"},{"issue":"2","key":"5405_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41409-018-0249-7","volume":"54","author":"S Tang","year":"2019","unstructured":"Tang S, Shen H, Qu C, Dai H, Zhu X, Xue S, Ding Z, Lu J, Wu D, Tang X (2019) Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes. Bone Marrow Transplant 54(2):236\u2013243. https:\/\/doi.org\/10.1038\/s41409-018-0249-7","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"5405_CR38","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1182\/bloodadvances.2021004430","volume":"5","author":"RJ Mitchell","year":"2021","unstructured":"Mitchell RJ, Kirkwood AA, Barretta E, Clifton-Hadley L, Lawrie E, Lee S, Leongamornlert D, Marks DI, McMillan AK, Menne TF, Papaemmanuil E, Patel B, Patrick P, Rowntree CJ, Zareian N, Alapi KZ, Moorman AV, Fielding AK (2021) IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial. Blood Adv 5(17):3322\u20133332. https:\/\/doi.org\/10.1182\/bloodadvances.2021004430","journal-title":"Blood Adv"},{"key":"5405_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13972","author":"Y Ito","year":"2023","unstructured":"Ito Y, Ozawa H, Eto T, Miyamoto T, Kamimura T, Ogawa R, Uchida N, Wake A, Fujisaki T, Ohno Y, Takase K, Okumura H, Takamatsu Y, Kawano N, Akashi K, Nagafuji K (2023) IKZF1(plus) alterations are not associated with outcomes in Philadelphia-positive acute lymphoblastic leukemia patients enrolled in the FBMTG ALL\/MRD2008 trial. Eur J Haematol. https:\/\/doi.org\/10.1111\/ejh.13972","journal-title":"Eur J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05405-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:03:22Z","timestamp":1697058202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05405-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,19]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["5405"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05405-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,19]]},"assertion":[{"value":"6 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individuals included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}